Complete mitochondrial DNA sequence of Alboglossiphonia lata Oka, 1910 (Rhynchobdellida: Glossiphoniidae) and its phylogenetic analysis

Panpan Jin; Yu Tian; Erhuan Zang; Lingchao Zeng; Zhaolei Zhang; Jinxin Liu; Linchun Shi

doi:10.1080/23802359.2024.2353385

Complete mitochondrial DNA sequence of Alboglossiphonia lata Oka, 1910 (Rhynchobdellida: Glossiphoniidae) and its phylogenetic analysis

Mitochondrial DNA B Resour. 2024 May 17;9(5):652-656. doi: 10.1080/23802359.2024.2353385. eCollection 2024.

Authors

Panpan Jin^{1

2}, Yu Tian^{1

3}, Erhuan Zang^{1

2}, Lingchao Zeng^{1

3}, Zhaolei Zhang^{2

3}, Jinxin Liu^{1

2}, Linchun Shi^{1

2}

Affiliations

¹ State Key Laboratory for Quality Assurance and Sustainable Use of Dao-di Herbs, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
² Key Laboratory of Chinese Medicine Resources Conservation, State Administration of Traditional Chinese Medicine of the People's Republic of China, Engineering Research Center of Chinese Medicine Resource of Ministry of Education, Beijing, China.
³ Hebei Key Laboratory of Study and Exploitation of Chinese Medicine, Chengde Medical University, Chengde, China.

Abstract

The complete mitochondrial genome of Alboglossiphonia lata (basionym: Glossiphonia lata), sourced from a biodiversity hotspot of China, has been determined and reported in this study. It was 15,236 bp in length and consisted of 13 protein-coding genes, 22 transfer RNA genes, 2 ribosomal RNA genes and three control regions. The mitogenome was deposited GenBank under the accession number PP165800. A. lata and other species within the Glossiphoniidae family were clustered together with high bootstrap values. The mitochondrial genome of A. lata provides valuable molecular data for further phylogenetic research on the Glossiphoniidae family.

Keywords: Alboglossiphonia lata; Glossiphoniidae; Mitochondrial genome; phylogentic analysis.

Grants and funding

This work was supported by Key project at central government level: The ability establishment of sustainable use for valuable Chinese medicine resources [2060302].